{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:03:29Z","timestamp":1773936209148,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010451","name":"Hunan Province Health Commission","doi-asserted-by":"publisher","award":["D202303047052"],"award-info":[{"award-number":["D202303047052"]}],"id":[{"id":"10.13039\/501100010451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010451","name":"Hunan Province Health Commission","doi-asserted-by":"publisher","award":["W20243031"],"award-info":[{"award-number":["W20243031"]}],"id":[{"id":"10.13039\/501100010451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017695","name":"Health Commission of Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2022JJ30850"],"award-info":[{"award-number":["2022JJ30850"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023JJ40850"],"award-info":[{"award-number":["2023JJ40850"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.pathol.2025.10.002","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T10:00:23Z","timestamp":1763373623000},"page":"19-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["IRF4 (MUM1) in B-cell malignancies: molecular mechanisms, biological functions, and clinical implications"],"prefix":"10.1016","volume":"58","author":[{"given":"Huihui","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doudou","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5604-5777","authenticated-orcid":false,"given":"Mingjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongling","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangsen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2213-5198","authenticated-orcid":false,"given":"Yewei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2025.10.002_bib1","article-title":"Regulatory effects of IRF4 on immune cells in the tumor microenvironment","volume":"14","author":"Lu","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.pathol.2025.10.002_bib2","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3390\/ijms25042153","article-title":"Roles of interferon regulatory factor 1 in tumor progression and regression: two sides of a coin","volume":"25","author":"Perevalova","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.pathol.2025.10.002_bib3","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10238-022-00968-0","article-title":"The dynamic functions of IRF4 in B cell malignancies","volume":"23","author":"Maffei","year":"2023","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.pathol.2025.10.002_bib4","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3389\/fimmu.2019.01176","article-title":"Direct inhibition of IRF-dependent transcriptional regulatory mechanisms associated with disease","volume":"10","author":"Antonczyk","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.pathol.2025.10.002_bib5","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1182\/blood.V95.6.2084","article-title":"A monoclonal antibody (MUM1p) detects expression of the MUM1\/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells","volume":"95","author":"Falini","year":"2000","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.pathol.2025.10.002_bib6","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221292","article-title":"A neomorphic mutation in the interferon activation domain of IRF4 causes a dominant primary immunodeficiency","volume":"220","author":"Thouenon","year":"2023","journal-title":"J Exp Med"},{"issue":"17","key":"10.1016\/j.pathol.2025.10.002_bib7","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.3390\/cancers14174314","article-title":"IRF4 as an oncogenic master transcription factor","volume":"14","author":"Wong","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pathol.2025.10.002_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1236889","article-title":"Human inborn errors of immunity associated with IRF4","volume":"14","author":"Thouenon","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.pathol.2025.10.002_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112077","article-title":"Roles of IRF4 in various immune cells in systemic lupus erythematosus","volume":"133","author":"Xiao","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"10.1016\/j.pathol.2025.10.002_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250093","article-title":"Puppet masters of B-cell progenitor acute lymphoblastic leukemia: the preB cell receptor and the interleukin 7 receptor \u03b1","volume":"53","author":"Das Gupta","year":"2023","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.pathol.2025.10.002_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1172641","article-title":"Kr\u00fcppel-like factor 2: a central regulator of B cell differentiation and plasma cell homing","volume":"14","author":"Wittner","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.pathol.2025.10.002_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1214095","article-title":"NF-kB's contribution to B cell fate decisions","volume":"14","author":"Guldenpfennig","year":"2023","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.pathol.2025.10.002_bib13","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202302465","article-title":"CXCR4: from B-cell development to B cell-mediated diseases","volume":"7","author":"Giorgiutti","year":"2024","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.pathol.2025.10.002_bib14","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1126\/science.275.5299.540","article-title":"Pillars article: requirement for the transcription factor LSIRF\/IRF4 for mature B and T lymphocyte function","volume":"275","author":"Mittr\u00fccker","year":"1997","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.pathol.2025.10.002_bib15","first-page":"563","article-title":"Diagnosis and differential diagnosis of large B-cell lymphoma with IRF4 rearrangement","volume":"53","author":"Luo","year":"2024","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"10.1016\/j.pathol.2025.10.002_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.exphem.2022.07.300","article-title":"Lineage- and stage-specific oncogenicity of IRF4","volume":"114","author":"Amanda","year":"2022","journal-title":"Exp Hematol"},{"issue":"10","key":"10.1016\/j.pathol.2025.10.002_bib17","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.3390\/cancers13102326","article-title":"The Role of AP-1 transcription factors in plasma cell biology and multiple myeloma pathophysiology","volume":"13","author":"Fan","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.pathol.2025.10.002_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/intimm\/dxac065","article-title":"Exploring novel functions of BACH2 in the acquisition of antigen-specific antibodies","volume":"35","author":"Ochiai","year":"2023","journal-title":"Int Immunol"},{"issue":"2","key":"10.1016\/j.pathol.2025.10.002_bib19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3390\/vaccines12020136","article-title":"Transcriptomic analysis reveals sixteen potential genes associated with the successful differentiation of antibody-secreting cells through the utilization of unfolded protein response mechanisms in robust responders to the influenza vaccine","volume":"12","author":"Tawfik","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"7","key":"10.1016\/j.pathol.2025.10.002_bib20","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1113019109","article-title":"Quantitative modeling of the terminal differentiation of B cells and mechanisms of lymphomagenesis","volume":"109","author":"Martinez","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.pathol.2025.10.002_bib21","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1038\/s44318-024-00077-6","article-title":"Accelerated plasma-cell differentiation in Bach2-deficient mouse B cells is caused by altered IRF4 functions","volume":"43","author":"Ochiai","year":"2024","journal-title":"Embo J"},{"issue":"7","key":"10.1016\/j.pathol.2025.10.002_bib22","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.4049\/jimmunol.1303216","article-title":"Transcription factor IRF4 regulates germinal center cell formation through a B cell-intrinsic mechanism","volume":"192","author":"Willis","year":"2014","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.pathol.2025.10.002_bib23","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/blood-2011-03-341412","article-title":"Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group","volume":"118","author":"Zhang","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.pathol.2025.10.002_bib24","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/leu.2016.27","article-title":"PU.1 cooperates with IRF4 and IRF8 to suppress pre-B-cell leukemia","volume":"30","author":"Pang","year":"2016","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.pathol.2025.10.002_bib25","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1038\/s41418-022-01005-z","article-title":"IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivity","volume":"29","author":"Das Gupta","year":"2022","journal-title":"Cell Death Differ"},{"issue":"7","key":"10.1016\/j.pathol.2025.10.002_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022628","article-title":"IRF4 is a suppressor of c-Myc induced B cell leukemia","volume":"6","author":"Pathak","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pathol.2025.10.002_bib27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/cells12010196","article-title":"Meta-analysis of MS-based proteomics studies indicates interferon regulatory factor 4 and nucleobindin1 as potential prognostic and drug resistance biomarkers in diffuse large B cell lymphoma","volume":"12","author":"Ejtehadifar","year":"2023","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.pathol.2025.10.002_bib28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00428-023-03516-7","article-title":"Prevalence of IRF4 rearrangement in large B-cell lymphomas of the Waldeyer\u2019s ring in adults","volume":"482","author":"Streich","year":"2023","journal-title":"Virchows Archiv"},{"key":"10.1016\/j.pathol.2025.10.002_bib29","article-title":"Large B-cell lymphoma with IRF4 rearrangement and follicular pattern: a differential diagnosis of follicular lymphoma","volume":"27","author":"Kim","year":"2022","journal-title":"Hum Pathol Rep"},{"issue":"1","key":"10.1016\/j.pathol.2025.10.002_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00428-022-03432-2","article-title":"Follicular lymphoma and marginal zone lymphoma: how many diseases?","volume":"482","author":"Laurent","year":"2023","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/j.pathol.2025.10.002_bib31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00428-023-03590-x","article-title":"Emerging entities: high-grade\/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP\/SH lymphoma workshop","volume":"483","author":"Quintanilla-Martinez","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2025.10.002_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.humpath.2023.08.008","article-title":"Follicular lymphoma and diffuse large B-cell lymphoma with BCL2 and IRF4 rearrangements in adult patients","volume":"141","author":"Yuan","year":"2023","journal-title":"Hum Pathol"},{"issue":"21","key":"10.1016\/j.pathol.2025.10.002_bib33","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood.2022015854","article-title":"Genomic profiling for clinical decision making in lymphoid neoplasms","volume":"140","author":"de Leval","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.pathol.2025.10.002_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41375-022-01764-1","article-title":"A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas","volume":"37","author":"Falini","year":"2023","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.pathol.2025.10.002_bib35","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3390\/cancers15082285","article-title":"Large B-cell lymphomas in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms-updated classification and new concepts","volume":"15","author":"Kurz","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.pathol.2025.10.002_bib36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-065X.2012.01113.x","article-title":"The diverse roles of IRF4 in late germinal center B-cell differentiation","volume":"247","author":"De Silva","year":"2012","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.pathol.2025.10.002_bib37","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1038\/s41467-023-41954-8","article-title":"Transcriptional reprogramming by mutated IRF4 in lymphoma","volume":"14","author":"Schleussner","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.pathol.2025.10.002_bib38","doi-asserted-by":"crossref","first-page":"104594","DOI":"10.1016\/j.cellimm.2022.104594","article-title":"Regulatory network of BLIMP1, IRF4, and XBP1 triad in plasmacytic differentiation and multiple myeloma pathogenesis","volume":"380","author":"Tang","year":"2022","journal-title":"Cell Immunol"},{"issue":"7201","key":"10.1016\/j.pathol.2025.10.002_bib39","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature07064","article-title":"IRF4 addiction in multiple myeloma","volume":"454","author":"Shaffer","year":"2008","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pathol.2025.10.002_bib40","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/hon.3016","article-title":"Dissecting the impact of bromodomain inhibitors on the interferon regulatory factor 4-MYC oncogenic axis in multiple myeloma","volume":"40","author":"Agnarelli","year":"2022","journal-title":"Hematol Oncol"},{"issue":"1","key":"10.1016\/j.pathol.2025.10.002_bib41","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1080\/16078454.2022.2124694","article-title":"Mechanism of immunomodulatory drug resistance and novel therapeutic strategies in multiple myeloma","volume":"27","author":"Zuo","year":"2022","journal-title":"Hematology"},{"issue":"4","key":"10.1016\/j.pathol.2025.10.002_bib42","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.stem.2020.12.017","article-title":"Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption","volume":"28","author":"Mondala","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"11","key":"10.1016\/j.pathol.2025.10.002_bib43","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/sj.leu.2401563","article-title":"Detection of MUM1\/IRF4-IgH fusion in multiple myeloma","volume":"13","author":"Yoshida","year":"1999","journal-title":"Leukemia"},{"issue":"Suppl 7","key":"10.1016\/j.pathol.2025.10.002_bib44","doi-asserted-by":"crossref","first-page":"vii143","DOI":"10.1093\/annonc\/mdq370","article-title":"Multiple myeloma","volume":"21","author":"Dimopoulos","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pathol.2025.10.002_bib45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.leukres.2018.07.025","article-title":"IRF4 in multiple myeloma-biology, disease and therapeutic target","volume":"72","author":"Agnarelli","year":"2018","journal-title":"Leuk Res"},{"issue":"15","key":"10.1016\/j.pathol.2025.10.002_bib46","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1111\/febs.16068","article-title":"The immunity-malignancy equilibrium in multiple myeloma: lessons from oncogenic events in plasma cells","volume":"289","author":"Perini","year":"2022","journal-title":"Febs J"},{"issue":"49","key":"10.1016\/j.pathol.2025.10.002_bib47","doi-asserted-by":"crossref","first-page":"85392","DOI":"10.18632\/oncotarget.19907","article-title":"Bone marrow IRF4 level in multiple myeloma: an indicator of peripheral blood Th17 and disease","volume":"8","author":"Bai","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.pathol.2025.10.002_bib48","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.3390\/jcm11092513","article-title":"The leading role of the immune microenvironment in multiple myeloma: a new target with a great prognostic and clinical value","volume":"11","author":"Desantis","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.pathol.2025.10.002_bib49","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1158\/2643-3230.BCD-23-0062","article-title":"Transcriptional heterogeneity overcomes super-enhancer disrupting drug combinations in multiple myeloma","volume":"5","author":"Welsh","year":"2024","journal-title":"Blood Cancer Discov"},{"issue":"9","key":"10.1016\/j.pathol.2025.10.002_bib50","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1182\/bloodadvances.2023010218","article-title":"C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myeloma","volume":"8","author":"Cheung","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.pathol.2025.10.002_bib51","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1182\/blood-2023-186864","article-title":"Discovery of first-in-class small molecule inhibitors of the IRF4-PU.1\/Spi-B interaction","volume":"142","author":"Agius","year":"2023","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.pathol.2025.10.002_bib52","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1182\/bloodadvances.2022007155","article-title":"Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase","volume":"7","author":"Harada","year":"2023","journal-title":"Blood Adv"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302525003368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302525003368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:04:59Z","timestamp":1773929099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302525003368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0031302525003368"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2025.10.002","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IRF4 (MUM1) in B-cell malignancies: molecular mechanisms, biological functions, and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2025.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}